Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-12 3:58 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | EcoR1 Capital LLC | 0 0% | -2,536,156 (Position Closed) | View |
2021-02-12 3:52 pm Sale | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 0 0% | -1,906,861 (Position Closed) | View |
2021-02-12 3:42 pm Sale | 13G | GLYCOMIMETICS INC GLYC | EcoR1 Capital LLC | 0 0% | -2,909,800 (Position Closed) | View |
2021-02-12 3:36 pm Sale | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | EcoR1 Capital LLC | 0 0% | -3,627,597 (Position Closed) | View |
2021-02-12 3:27 pm Unchanged | 13G | CHIASMA INC CHMA | EcoR1 Capital LLC | 0 0% | 0 (Unchanged) | View |
2021-02-12 3:18 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | EcoR1 Capital LLC | 1,509,812 3.5% | -577,500 (-27.67%) | View |
2021-01-26 12:21 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | EcoR1 Capital LLC | 4,368,500 6.8% | 4,368,500 (New Position) | View |
2021-01-22 4:27 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | EcoR1 Capital LLC | 4,702,160 6.6% | 4,702,160 (New Position) | View |
2021-01-14 4:59 pm Purchase | 13G | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 3,813,324 13.9% | 1,847,224 (+93.95%) | View |
2021-01-04 4:42 pm Purchase | 13G | ARS PHARMACEUTICALS, INC SPRY | EcoR1 Capital LLC | 2,533,635 7.3% | 2,533,635 (New Position) | View |
2021-01-04 4:30 pm Purchase | 13G | GRITSTONE BIO INC GRTS | EcoR1 Capital LLC | 4,934,932 9.99% | 4,934,932 (New Position) | View |
2020-11-02 4:04 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 5,275,000 9.8% | 5,275,000 (New Position) | View |
2020-08-28 4:06 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | EcoR1 Capital LLC | 2,328,492 6.5% | 2,328,492 (New Position) | View |
2020-07-20 4:34 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | EcoR1 Capital LLC | 2,909,800 6.7% | 2,909,800 (New Position) | View |
2020-06-17 4:42 pm Purchase | 13G | XENCOR INC XNCR | EcoR1 Capital LLC | 4,547,072 8% | 4,547,072 (New Position) | View |
2020-05-29 4:13 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 5,033,861 12.8% | 3,732,148 (+286.71%) | View |
2020-05-29 4:05 pm Purchase | 13G | GERON CORP GERN | EcoR1 Capital LLC | 28,846,154 9.1% | 28,846,154 (New Position) | View |
2020-05-01 5:29 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 2,642,218 8.8% | 2,642,218 (New Position) | View |
2020-04-24 4:35 pm Purchase | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 1,906,861 6.6% | 188,661 (+10.98%) | View |
2020-03-26 4:21 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | EcoR1 Capital LLC | 2,536,156 6.5% | 2,536,156 (New Position) | View |